Â鶹´«Ã½

ÌýhasÌýset the next intake date for funding applications inÌý​theirÌýrolling, open call process. BioCanRx buildsÌýon past and ongoing investments in the area of cancer biotherapeutics that have a clear path to, or are ready for, clinical trials.Ìý​The network isÌýstrengthening Canada's ability to translate the unfolding promise of immune-based cancer therapies into benefits for patients.
As an open call, this opportunityÌýis open to all investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).

LOIs are now being acceptedÌýfor the​Ìýfour research programs:

·ÌýÌýÌýÌýÌýÌýÌýÌýÌýClinical Trials Program
·ÌýÌýÌýÌýÌýÌýÌýÌýÌýEnabling Studies Program
·ÌýÌýÌýÌýÌýÌýÌýÌýÌýCatalyst Program
·ÌýÌýÌýÌýÌýÌýÌýÌýÌýClinical, Social and Economic Impact Program

If you have questions regarding your eligibility (or that of your institution) or how your project would fit within

​B¾±´Ç°ä²¹²Ô¸é³æ's research program, you are encouraged to contactÌýDr. Kelley Parato, Director of Scientific Affairs at BioCanRx.
Ìý
Important Dates:
The next intake deadline isÌýNovember 9, 2016, byÌý11:59 p.m. EDT.

Contact information:Ìý
For more information, see theÌýÌýat the BioCanRx website or contact:
Dr. Kelley Parato
Tel:Ìý613-739-6595

Email:Ìýkeparato@biocanrx.com